Hyperglycemia-induced insulin resistance in diabetic dyslipidemic Yucatan swine

Comparative Medicine

Volumn 53, Issue 1, 2003, Pages 53-64

  Otis, Christine R ^a   Wamhoff, Brian R ^a   Sturek, Michael ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; ATORVASTATIN; CHOLESTEROL; DIAZEPAM; GLUCOSE; INSULIN; ISOFLURANE; SOMATOSTATIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HYPERGLYCEMIA; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; LIPID DIET; MALE; NONHUMAN; PANCREAS; SWINE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; HYPERLIPIDEMIAS; INSULIN RESISTANCE; MALE; SWINE;

EID: 0037297201     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Dixon, J. L., J. D. Stoops, J. L. Parker, M. H. Laughlin, G. A. Weisman, and M. Sturek. 1999. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler. Thromb. Vasc. Biol. 19:2981-2992.
2. 2+ signaling associated with diabetic dyslipidemia. J. Vasc. Res. 39:208-220.
3. Dixon, J. L., S. Shen, J. V. Vuchetich, E. Wysocka, G. Sun, and M. Sturek. 2002. Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile. J. Lipid Res. 43:1618-1629.
4. Gerrity, R. G., R. Natarajan, J. L. Nadler, and T. Kimsey. 2001. Diabetes-induced accelerated atherosclerosis in swine. Diabetes 50:1654-1665.
5. Natarajan, R., R. G. Gerrity, J. L. Gu, L. Lanting, L. Thomas, and J. L. Nadler. 2002. Role of 12-lipoxygenase and oxidant stress in hyperglycemia-induced acceleration of atherosclerosis in a diabetic pig model. Diabetologia 45:125-133.
6. Suzuki, L. A., M. Poot, R. G. Gerrity, and K. E. Bornfeldt. 2001. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis. (Lack of direct growth-promoting effects of high glucose levels.). Diabetes 50:851-860.
7. Schaper, W. and J. Schaper. 1993. Collateral circulation, p. 1-406. Kluwer, New York.
8. Hill, B. J. F., J. L. Dixon, and M. Sturek. 2001. Effect of atorvastatin on intracellular calcium uptake in coronary smooth muscle cells from diabetic pigs fed an atherogenic diet. Atherosclerosis 159:117-124.
9. Hayden, J. M. and P. D. Reaven. 2000. Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors. Curr. Opin. Lipidol. 11:519-528.
10. Reaven, G. M. 2000. Insulin resistance - how important is it to treat? Exp. Clin. Endocrinol. Diabetes 108:S274-S280.
11. Kahn, C. R. 1994. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066-1084.
12. Garvey, W. T., L. Maianu, J. H. Zhu, G. Brechtel-Hook, P. Wallace, and A. D. Baron. 1998. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J. Clin. Invest. 101:2377-2386.
13. Calles-Escandón, J., S. A. Mirza, B. E. Sobel, and D. J. Schneider. 1998. Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects. Diabetes 47:290-293.
14. Magnan, C., M. Gilbert, and B. B. Kahn. 1996. Chronic free fatty acid infusion in rats results in insulin resistance but no alteration in insulin-responsive glucose transporter levels in skeletal muscle. Lipids 31:1141-1149.
15. Yki-Jarvinen, H. and V. A. Koivisto. 1986. Natural course of insulin resistance in type 1 diabetes. N. Engl. J. Med. 315:224-230.
16. Maggs, D. G., R. Jacob, F. Rife, S. Caprio, W. V. Tamborlane, and R. S. Sherwin. 1997. Counterregulation in peripheral tissues. Effect of systemic hypoglycemia on levels of substrates and catecholamines in human skeletal muscle and adipose tissue. Diabetes 46:70-76.
17. Mathoo, J. M. R., Z. Q. Shi, A. Klip, and M. Vranic. 1999. Opposite effects of acute hypoglycemia and acute hyperglycemia on glucose transport and glucose transporters in perfused rat skeletal muscle. Diabetes 48:1281-1288.
18. Bergman, R. N., D. T. Finegood, and M. Ader. 1985. Assessment of insulin sensitivity in vivo. Endocr. Rev. 6:45-86.
19. Coates, P. A., S. D. Luzio, P. Brunel, and D. R. Owens. 1995. Comparison of estimates of insulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM. Diabetes 44:631-635.
20. Saad, M. F., R. L. Anderson, A. Laws, R. M. Watanabe, W. W. Kades, Y.-D. Chen, E. Sands, D. Pei, P. J. Savage, and R. N. Bergman. 1994. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43:1114-1121.
21. Cefalu, W. T., J. D. Wagner, A. D. Bell-Farrow, Z. Q. Wang, M. R. Adams, G. Toffolo, and C. Cobelli. 1994. The effects of hormonal replacement therapy on insulin sensitivity in surgically postmenopausal cynomolgus monkeys (Macaca fascicularis). Am. J. Obstet. Gynecol. 171:440-445.
22. Kahn, S. E., D. K. McCulloch, M. W. Schwartz, J. P. Palmer, and D. Porte, Jr. 1992. Effect of insulin resistance and hyperglycemia on proinsulin release in a primate model of diabetes mellitus. J. Clin. Endocrinol. Metab. 74:192-197.
23. McCulloch, D. K., P. K. Raghu, C. Johnston, L. J. Klaff, S. E. Kahn, J. C. Beard, W. K. Ward, E. A. Benson, D. J. Koerker, R. N. Bergman, and J. P. Palmer. 1988. Defects in beta-cell function and insulin sensitivity in normoglycemic streptozotocin-treated baboons: a model of preclinical insulin-dependent diabetes. J. Clin. Endocrinol. Metab. 67:785-792.
24. Nagulesparan, M., P. J. Savage, R. H. Unger, and P. H. Bennett. 1979. A simplified method using somatostatin to assess in vivo insulin resistance over a range of obesity. Diabetes 28:980-983.
25. Nagulesparan, M., P. J. Savage, W. C. Knowler, G. C. Johnson, and P. H. Bennett. 1982. Increased in vivo insulin resistance in nondiabetic Pima Indians compared with Caucasians. Diabetes 31:952-956.
26. Harano, Y., S. Ohgaku, K. Kosugi, H. Yasuda, T. Nakano, M. Kobayashi, H. Hidaka, K. Izumi, A. Kashiwagi, and Y. Shigeta. 1981. Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin, and somatostatin infusion. J. Clin. Endocrinol. Metab. 52:982-987.
27. Nagulesparan, M., P. J. Savage, D. M. Mott, G. C. Johnson, R. H. Unger, and P. H. Bennett. 1980. Increased insulin resistance in obese, glucose-intolerant southwestern American Indians: evidence for a defect not explained by obesity. J. Clin. Endocrinol. Metab. 51:739-743.
28. Greco, A. V., A. G. Rabuzzi, L. Almonte, R. Manna, A. Bertoli, and G. Ghirlanda. 1979. Glucose, insulin and somatostatin infusion for the determination of insulin resistance in liver cirrhosis. Horm. Metab. Res. 11:547-549.
29. Harano, Y., H. Hidaka, K. Takatsuki, S. Ohgaku, M. Haneda, S. Motoi, K. Kawgoe, Y. Shigeta, and H. Abe. 1978. Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. Metabolism 27:1449-1452.
30. Ratzmann, K. P., W. Besch, S. Witt, and B. Schulz. 1981. Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance. Diabetologia 21:192-197.
31. Asayama, K., S. Amemiya, K. Kato, and M. Shimizu. 1982. In vivo insulin sensitivity and insulin binding to erythrocytes in children: insulin resistance in obese children. Endocrinol. Jpn. 29:575-581.
32. Piatti, P. M., L. D. Monti, A. Caumo, G. Santambrogio, F. Magni, M. Galli-Kienle, S. Costa, A. E. Pontiroli, K. G. M. M. Alberti, and G. Pozza. 1995. The continuous low dose insulin and glucose infusion test: a simplified and accurate method for the evaluation of insulin sensitivity and insulin secretion in population studies. J. Clin. Endocrinol. Metab. 80:34-40.
33. Polderman, K. H., L. J. G. Gooren, H. Asscheman, A. Bakker, and R. J. Heine. 1994. Induction of insulin resistance by androgens and estrogens. J. Clin. Endocrinol. Metab. 79:265-271.
34. Kaburagi, Y., K. Momomura, R. Yamamoto-Honda, K. Tobe, Y. Tamori, H. Sakura, Y. Akanuma, Y. Yazaki, and T. Kadowaki. 1995. Site-directed mutagenesis of the juxtamembrane domain of the human insulin receptor. J. Biol. Chem. 268:16610-16622.
35. Tappy, L., D. Randin, P. Vollenweider, L. Vollenweider, N. Paquot, U. Scherrer, P. Schneiter, P. Nicod, and E. Jequier. 1994. Mechanisms of dexamethasone-induced insulin resistance in healthy humans. J. Clin. Endocrinol. Metab. 79:1063-1069.
36. Holmäng, A., C. Nilsson, M. Niklasson, B.-M. Larsson, and P. Lönroth. 1999. Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin. Diabetes 48:106-111.
37. Akinmokun, A., P. L. Selby, K. Ramaiya, and K. G. M. Alberti. 1992. The short insulin tolerance test for the estimation of insulin sensitivity: a comparison with the euglycaemic clamp. Diabetic Med. 9:432-437.
38. Bonora, E., P. Moghetti, C. Zancanaro, M. Cigolini, M. Querena, V. Cacciatori, A. Cognati, and M. Muggeo. 1989. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J. Clin. Endocrinol. Metab. 68:374-378.
39. Dimitriadis, G., B. Leighton, M. Parry-Billings, S. Sasson, M. Young, U. Krause, S. Bevan, T. Piva, G. Wegener, and E. A. Newsholme. 1997. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem. J. 321:707-712.
40. Han, X. X. and A. Bonen. 1998. Epinephrine translocates GLUT-4 but inhibits insulin-stimulated glucose transport in rat muscle. Am. J. Physiol. 274:E700-E707.
41. Weinstein, S. P., C. M. Wilson, A. Pritsker, and S. W. Cushman. 1998. Dexamethasone inhibits insulin-stimulated recruitment of GLUT4 to the cell surface in rat skeletal muscle. Metabolism 47:3-6.
42. Harrison, L. C., F. I. R. Martin, and R. A. Melick. 1976. Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects. J. Clin. Invest. 58:1435-1441.
43. Harrison, L. C. and A. P. King-Roach. 1976. Insulin sensitivity of adipose tissue in vivo and the response to exogenous insulin in obese human subjects. Metabolism 25:1095-1101.
44. Panepinto, L. M., R. W. Phillips, S. Norden, P. C. Pryor, and R. Cox. 1983. A comfortable, minimum stress method of restraint for Yucatan miniature swine. Lab. Anim. Sci. 33:95-97.
45. Phillips, R. W., N. Westmoreland, L. Panepinto, and G. L. Case. 1982. Dietary effects on metabolism of Yucatan miniature swine selected for low and high glucose utilization. J. Nutr. 112:104-111.
46. Panepinto, L. M., R. W. Phillips, N. W. Westmoreland, and J. L. Cleek. 1982. Influence of genetics and diet on the development of diabetes in Yucatan miniature swine. J. Nutr. 112:2307-2313.
47. Phillips, R. W., L. M. Panepinto, R. Spangler, and N. Westmoreland. 1982. Yucatan miniature swine as a model for the study of human diabetes-mellitus. Diabetes 31:30-36.
48. Steiner, G. 1995. Dyslipoproteinemias in diabetes. Clin. Invest. Med. 18:282-287.
49. Boullion, R. D., E. A. Mokelke, B. R. Wamhoff, C. R. Otis, J. Wenzel, J. L. Dixon, and M. Sturek. 2002. Porcine model of diabetic dyslipidemia: insulin and feed algorithms for mimicking diabetes in humans. Comp. Med. 53:42-52.
50. Bailie, M. B., S. K. Wixson, and M. S. Landi. 1986. Vascularaccess-port implantation for serial blood sampling in conscious swine. Lab. Anim. Sci. 36:431-433.
51. Rerup, C. C. 1970. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol. Rev. 22:485-517.
52. Pompos, L. J., D. B. Carter, J. M. Criley, C. Otis, A. Czarnik, J. R. Turk, M. Sturek, and M. J. Kennett. 2000. Fluid loading provides protection from the nephrotoxic effects of alloxan in the porcine diabetes mellitus model. Contemp. Top. Lab. Anim. Sci. 39:100.
53. Reaven, G. M., W. S. Sageman, and R. S. Swenson. 1977. Development of insulin resistance in normal dogs following alloxan-induced insulin deficiency. Diabetologia 133:459-462.
54. Skarda, R. T., R. M. Bednarski, W. W. Muir, and J. A. E. Hubbell. 1995. Handbook of veterinary anesthesia, p. 1-510. Mosby, St. Louis.
55. Laber-Laird, K., A. Smith, M. M. Swindle, and J. Colwell. 1992. Effect of isoflurane anesthesia on glucose tolerance and insulin secretion in Yucatan minipigs. Lab. Anim. Sci. 42:579-581.
56. Dimitrakoudis, D., T. Ramlal, S. Rastogi, M. Vranic, and A. Klip. 1992. Glycaemia regulates the glucose transporter number in the plasma membrane of rat skeletal muscle. Biochem. J. 284:341-348.
57. Richardson, J. M., T. W. Balon, J. L. Treadway, and J. E. Pessin. 1991. Differential regulation of glucose transporter activity and expression in red and white skeletal muscle. J. Biol. Chem. 266:12690-12694.
58. Hansen, B. F., S. A. Hansen, T. Ploug, J. F. Bak, and E. A. Richter. 1992. Effects of glucose and insulin on development of impaired insulin action in muscle. Am. J. Physiol. 262:E440-E446.
59. Richter, E. A., B. F. Hansen, and S. A. Hansen. 1988. Glucose-induced insulin resistance of skeletal-muscle glucose transport and uptake. Biochem. J. 252:733-737.
60. Rudel, L. L., J. S. Parks, C. C. Hedrick, M. Thomas, and K. Williford. 1998. Lipoprotein and cholesterol metabolism in diet-induced coronary artery atherosclerosis in primates. Role of cholesterol and fatty acids. Prog. Lipid Res. 37:353-370.
61. Chaturvedi, N., L. K. Stevens, J. H. Fuller, and The WHO Multinational Study Group. 1995. Mortality and morbidity associated with body weight in people with IDDM: the WHO multinational study of vascular disease in diabetes. Diabetes Care 18:761-765.
62. Stanley, W. C., J. J. Dore, J. L. Hall, C. D. Hamilton, R. D. Pizzurro, and D. A. Roth. 2001. Diabetes reduces right atrial β-adrenergic signaling but not agonist stimulation of heart rate in swine. Can. J. Physiol. Pharmacol. 79:346-351.
63. Litwak, K. N., W. T. Cefalu, and J. D. Wagner. 1998. Streptozotocin-induced diabetes mellitus in cynomolgus monkeys: changes in carbohydrate metabolism, skin glycation, and pancreatic islets. Lab. Anim. Sci. 48:172-178.
64. Araya, A. V., I. Atwater, M.A. Navia, and S. Jeffs. 2000. Evaluation of insulin resistance in two kinds of South American camelids: llamas and alpacas. Comp. Med. 50:490-494.
65. Wangsness, P. J., R. J. Martin, and J. H. Gahagan. 1977. Insulin and growth hormone in lean and obese pigs. Am. J. Physiol. 233:E104-E108.